Packaging that promotes patient compliance with drug regimens may be one area that gets additional attention as a result of healthcare reform. Further development and use of such packaging will, of course, be another driver of drug costs, but it may net a decrease in the overall cost of healthcare.
Use of compliance packaging may in particular grow for cold chain products, says one respondent to a late-September survey by Healthcare Packaging. Another cites clinical trials: "Our customers are usually willing to pay more for compliance packaging features if they are crucial to the particular study."
One survey-taker expresses concern that compliance features could impact the sterility and integrity of drug products.
- see the article